Q2 2020 Holdings
Filed 2020-08-14 | 125 holdings | $553.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-08-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $218.7M | 6,706,268 | 39.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $66.1M | 1,543,790 | 11.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $48.6M | 16,584,802 | 8.8% |
| Agio Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $48.1M | 900,000 | 8.7% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $36.0M | 2,058,068 | 6.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $23.8M | 528,776 | 4.3% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $23.2M | 480,000 | 4.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $21.5M | 2,577,043 | 3.9% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $12.9M | 3,085,458 | 2.3% |
| Alector Inc(ALEC) | COM | 014442107 | $12.5M | 511,731 | 2.3% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $9.7M | 545,285 | 1.8% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $8.5M | 1,750,000 | 1.5% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $7.0M | 15,489 | 1.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $4.1M | 50,000 | 0.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $4.0M | 400,000 | 0.7% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $2.6M | 561,574 | 0.5% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $716.0K | 52,724 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $379.8K | 25,182,364 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $368.8K | 5,842,100 | 0.1% |
| Retrophin Inc | NOTE 2.500% 9/1 | 761299AB2 | $350.0K | $45,000,000 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $324.2K | 11,809,494 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $316.4K | 2,771,050 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $261.3K | 2,141,410 | 0.0% |
| Cytokinetics Inc | NOTE 4.000%11/1 | 23282WAA8 | $238.3K | $10,000,000 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $190.2K | 3,513,572 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $170.6K | 55,042,465 | 0.0% |
| Collegium Pharmaceutical Inc | NOTE 2.625% 2/1 | 19459JAA2 | $157.2K | $17,500,000 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $155.9K | 11,532,467 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $147.6K | 3,514,358 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $134.8K | 1,395,017 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $132.5K | 4,907,139 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $129.2K | 3,580,999 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $121.5K | $9,000,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $107.5K | 899,972 | 0.0% |
| Quotient LTD | COM | G73268107 | $98.3K | 13,289,054 | 0.0% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $80.5K | 6,433,277 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $80.4K | 15,711,334 | 0.0% |
| Frequency Therapeutics Inc | COM | 35803L108 | $70.5K | 3,034,296 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $68.9K | 1,095,129 | 0.0% |
| Provention BIO Inc(PRVBUSD) | COM | 74374N102 | $63.9K | 4,525,711 | 0.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $59.2K | 3,659,381 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $58.1K | 1,250,000 | 0.0% |
| Vapotherm Inc | COM | 922107107 | $54.9K | 1,338,760 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $53.7K | 688,624 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $51.9K | 1,960,139 | 0.0% |
| Neptune Wellness Solutions I | COM | 64079L105 | $51.6K | 18,436,906 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $45.8K | 2,189,010 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $45.8K | 1,050,003 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $44.3K | 15,919,925 | 0.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $44.0K | 1,104,656 | 0.0% |